Akoya Biosciences Inc - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
AKYA Nasdaq 3841 https://www.akoyabio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Akoya Biosciences Inc

Akoya to Report Third Quarter 2021 Financial Results on November 8th, 2021 - Oct 19th, 2021 12:05 pm
Akoya Biosciences Appoints Diagnostics Industry Pioneer Myla Lai-Goldman, MD, to its Board of Directors - Sep 22nd, 2021 12:05 pm
Akoya Biosciences to Present at the Morgan Stanley 19th Annual Global Healthcare Conference - Aug 31st, 2021 12:05 pm
Akoya Biosciences Inc (AKYA) Q2 2021 Earnings Call Transcript - Aug 11th, 2021 6:12 pm
Akoya Reports 53% Revenue Growth in the Second Quarter of 2021 - Aug 10th, 2021 8:05 pm
Akoya Biosciences to Present at the Canaccord 41st Annual Growth Conference - Aug 3rd, 2021 12:05 pm
Akoya to Report Second Quarter 2021 Financial Results on August 10, 2021 - Jul 20th, 2021 12:05 pm
Akoya Announces Publication of the MITRE Study, the First Multi-Institutional Analytical Demonstration of a Spatial Biology Workflow, in the Journal for ImmunoTherapy of Cancer - Jul 19th, 2021 12:05 pm
What Type Of Shareholders Own The Most Number of Akoya Biosciences, Inc. (NASDAQ:AKYA) Shares? - Jul 16th, 2021 5:16 am
Akoya to Partner with Nikon, CrestOptics and Andor to Enable New Spatial Biology Applications through the Imaging Innovators (I2) Network - Jun 29th, 2021 12:05 pm
Akoya Biosciences Appoints Diagnostics Industry Leader Scott Mendel to its Board of Directors - Jun 25th, 2021 12:05 pm
Akoya to Help Support Leading Philanthropic Organization with Spatial Phenotyping Capabilities - Jun 15th, 2021 12:05 pm
Akoya Announces Publication of New Immunotherapy Biomarker Signature in Science, Leveraging Principles of Astronomy and Pathology - Jun 10th, 2021 6:00 pm
Akoya Set to Join Russell 3000® Index - Jun 9th, 2021 12:02 pm
Akoya and AstraZeneca to Collaborate on Spatial Biology Approach to Profiling Tumor-Immune Biology - Jun 4th, 2021 12:05 pm
Akoya Announces Rollout of Strategic Clinical Research Program to Advance Adoption of Spatial Biology for Clinical Applications - Jun 2nd, 2021 12:05 pm
Akoya Reports First Quarter 2021 Financial Results and Issues Full Year 2021 Guidance - May 18th, 2021 8:05 pm
Akoya Biosciences Inc to Host Earnings Call - May 18th, 2021 7:15 pm
Akoya and ZEISS to Co-Market Innovative CODEX® Spatial Biology Workflow - May 17th, 2021 12:05 pm
Akoya to Report First Quarter 2021 Financial Results on May 18, 2021 - May 12th, 2021 12:05 pm